Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study

被引：0
|
作者：
Koh, Adrian H. C. [1 ]
Parikh, Soumil [2 ]
机构：
[1] Camden Med Ctr, Med Retina Eye & Retina Surg, Singapore, Singapore
[2] Novartis Pharma AG, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
831
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Evaluation of indocyanine green angiographic features in symptomatic macular polypoidal choroidal vasculopathy over 24 months: results from the EVEREST II study
    Lim, Tock H.
    Parikh, Soumil
    Tan, Colin S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [42] Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
    Kumar, Atul
    Mutha, Vineet
    Sundar, Dheepak M.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2018, 66 (08) : 1128 - 1129
  • [43] One-year Results of Intravitreal Ranibizumab Combined with Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Yamanouchi, Daisuke
    Sakurai, Madoka
    Baba, Takayuki
    Kitahashi, Masayasu
    Yokouchi, Hirotaka
    Kubota-Taniai, Mariko
    Yamamoto, Shuichi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [44] Efficacy of Photodynamic Therapy With or Without Intravitreal Anti-VEGF Injection for the Treatment of Polypoidal Choroidal Vasculopathy
    Yu, H.
    Kim, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] INTRAVITREAL AFLIBERCEPT WITH AND WITHOUT RESCUE PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY: 2-YEAR RESULTS OF THE PLANET STUDY
    Ao, Paul Mitchell
    Iida, Tomohiro
    Ogura, Yuichiro
    Chen, Shih Jen
    Wong, Tien Yin
    Zhang, Eric
    Leal, Sergio
    Ishibashi, Tatsuro
    Cheung, Gemmy
    Lee, Won Ki
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 127 - 128
  • [46] One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakurai, Madoka
    Baba, Takayuki
    Kitahashi, Masayasu
    Yokouchi, Hirotaka
    Kubota-Taniai, Mariko
    Bikbova, Guzel
    Oshitari, Toshiyuki
    Yamamoto, Shuichi
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 235 - 241
  • [47] Infographic: Everest II study "Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment"
    Vyas, Chinmayi Himanshuroy
    Lott, Pooi Wah
    Gunatheesan, Rubamalar
    Sim, Shaun Sebastian
    Sun, Christopher Ziyu
    Teo, Kelvin Yi Chong
    Cheung, Chui Ming Gemmy
    EYE, 2022, 36 (06) : 1140 - 1141
  • [48] Infographic: Everest II study “Which is superior? Combination therapy or monotherapy for polypoidal choroidal vasculopathy (PCV) treatment”
    Chinmayi Himanshuroy Vyas
    Pooi Wah Lott
    Rubamalar Gunatheesan
    Shaun Sebastian Sim
    Christopher Ziyu Sun
    Kelvin Yi Chong Teo
    Chui Ming Gemmy Cheung
    Eye, 2022, 36 : 1140 - 1141
  • [49] ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Wong, Ian Y.
    Shi, Xuan
    Gangwani, Rita
    Iu, Lawrence P.
    Fung, Nicholas
    Li, Qing
    Ng, Alex L. K.
    Li, Xiaoxin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 725 - 730
  • [50] THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY Retrospective Study and Systematic Review
    Wong, Chee Wai
    Cheung, Chui Ming Gemmy
    Mathur, Ranjana
    Li, Xiang
    Chan, Choi Mun
    Yeo, Ian
    Wong, Edmund
    Lee, Shu Yen
    Wong, Doric
    Wong, Tien Yin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1577 - 1593
12345